Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | IDO1 | P14902 | 2/20 | 0.51 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | PDE4A | P27815 | 3/20 | 0.50 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.50 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.50 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.49 |
| ▸ | RELA | Q04206 | 2/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.49 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10353459 | 0.87 | CYP1A2 (0.74) | CYP1A2LMNAPDE4APDE4BPDE4C | |
| SCHEMBL1151416 | 0.84 | CYP1A2 (0.58) | CYP1A2NOTUMLMNAPDE4APDE4B | |
| SCHEMBL7298232 | 0.81 | CYP1A2 (0.65) | CYP1A2LMNAPDE4APDE4BPDE4C | |
| SCHEMBL4048920 | 0.79 | CYP1A2 (0.62) | CYP1A2IDO1NOTUMLMNAPDE4A | |
| SCHEMBL2152938 | 0.79 | CYP1A2 (0.62) | CYP1A2LMNAPDE4APDE4BPDE4C | |
| SCHEMBL10066830 | 0.79 | CYP1A2 (0.62) | CYP1A2LMNAPDE4APDE4BPDE4C | |
| SCHEMBL11628763 | 0.79 | KMT2A (0.64) | CYP1A2IDO1NOTUMLMNAPDE4A | |
| SCHEMBL2829502 | 0.79 | CYP1A2 (0.62) | CYP1A2IDO1LMNAPDE4APDE4B | |
| SCHEMBL8887885 | 0.79 | CYP1A2 (0.50) | CYP1A2IDO1NOTUMLMNASMN1; SMN2 | |
| SCHEMBL1769732 | 0.79 | JAK2 (0.62) | CYP1A2IDO1NOTUMLMNAPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117510470-A | Pyridazinone compounds and application thereof | 暨南大学 | 2024-02-06 | — | — | CN | disclosed |
| US-9221806-B2 | 2-(heterocyclylbenzyl)pyridazinone derivatives | MERCK PATENT GMBH (DE) | 2015-12-29 | — | — | US | disclosed |
| EP-2049531-B1 | 2-(HETEROCYCLYLBENZYL)PYRIDAZINONE DERIVATIVES | MERCK PATENT GMBH (DE) | 2014-09-24 | — | — | EP | disclosed |
| US-8623870-B2 | Pyridazinone derivatives | MERCK PATENT GMBH (DE) | 2014-01-07 | — | — | US | disclosed |
| US-8623870-B2 | Pyridazinone derivatives | MERCK PATENT GMBH (DE) | 2014-01-07 | — | — | US | disclosed |
| US-8623870-B2 | Pyridazinone derivatives | MERCK PATENT GMBH (DE) | 2014-01-07 | — | — | US | disclosed |
| CN-101501028-B | 2- (heterocyclylbenzyl) pyridazinone derivatives | MERCK PATENT GMBH | 2013-09-11 | — | — | CN | disclosed |
| US-20130131037-A1 | 2-(HETEROCYCLYLBENZYL)PYRIDAZINONE DERIVATIVES | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2013-05-23 | — | — | US | disclosed |
| US-8435981-B2 | 2-(heterocyclylbenzyl)pyridazinone derivatives | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 2013-05-07 | — | — | US | disclosed |
| EP-2373647-B1 | PYRIDAZINONE DERIVATIVES | MERCK PATENT GMBH (DE) | 2012-10-31 | — | — | EP | disclosed |
| CN-101326167-A | Pyridiazinone derivatives for tumour treatment | MERCK PATENT GMBH (DE) | 2008-12-17 | — | — | CN | disclosed |
| US-20080293719-A1 | Pyridiazinone Derivatives for the Treatment of Tumours | MERCK PATENT GESELLSCHAFT (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080293719-A1 | Pyridiazinone Derivatives for the Treatment of Tumours | MERCK PATENT GESELLSCHAFT (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080293719-A1 | Pyridiazinone Derivatives for the Treatment of Tumours | MERCK PATENT GESELLSCHAFT (DE) | 2008-11-27 | — | — | US | disclosed |
| EP-1960370-A1 | PYRIDIAZINONE DERIVATIVES FOR TUMOUR TREATMENT | Merck Patent GmbH (DE) | 2008-08-27 | — | — | EP | disclosed |
| WO-2008017361-A2 | 2-(HETEROCYCLYLBENZYL)PYRIDAZINONE DERIVATIVES | MERCK PATENT GMBH (DE) | 2008-02-14 | — | — | WO | disclosed |
| WO-2007065518-A1 | PYRIDIAZINONE DERIVATIVES FOR TUMOUR TREATMENT | MERCK PATENT GMBH (DE) | 2007-06-14 | — | — | WO | disclosed |
| WO-2007065518-A1 | PYRIDIAZINONE DERIVATIVES FOR TUMOUR TREATMENT | MERCK PATENT GMBH (DE) | 2007-06-14 | — | — | WO | disclosed |
| US-4112095-A | 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents | AMERICAN CYANAMID COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4092311-A | Hypotensive alkyl-3-[6-(aryl)-3-pyridazinyl]-carbazates | AMERICAN CYANAMID COMPANY (US) | 1978-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131037-A1 | 2-(HETEROCYCLYLBENZYL)PYRIDAZINONE DERIVATIVES | RET, MET, ERBB2 | CYP1A2 714/4885IDO1 1331/4885NOTUM 4069/4885 |
| US-20080293719-A1 | Pyridiazinone Derivatives for the Treatment of Tumours | MET, RET, ERBB2 | CYP1A2 796/4885IDO1 930/4885NOTUM 4250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.